Visby Medical raises $55M to bring lab-grade STI testing home

| Posted on |

Here’s a structured breakdown of the information regarding Visby Medical:

Company Information

  • Startup: Visby Medical
  • Founder: Adam de la Zerda (Israeli professor)

Fundraising Details

  • Recent Fundraise Amount: Approximately $55 million (potential to reach $65 million)
  • Total Funds Raised to Date: $487 million
  • Funding Round Series: Not specified (just referred to as a funding round)
  • Date of Fundraise: Not explicitly mentioned in the provided text

Investors

  • Lead Investor: Catalio Capital Management
  • Existing Investors:
    • ND Capital
    • Cedars-Sinai Medical Center
    • Blue Water Life Science Advisors
    • Pitango Ventures
    • John Doerr

Additional Comments by Investors

  • Itaai Harel (Pitango Health) noted:
    • Early investment made six years ago.
    • The company has progressed to advanced commercial phases.
    • Product allows lab-quality PCR testing at home.

Strategic Leaders Joined Board

  • Isaac Ro: Partner at Catalio, joined as a board observer.
  • Chuck Alpuche: Independent director (former COO roles in various organizations).

Product Information

  • Type of Products: PCR-based diagnostic kits for rapid home testing.
  • Notable Product: At-home Women’s Sexual Health Test, FDA-authorized.

Future Plans

  • Funding to accelerate the launch and distribution of the new test.

If you need any more details or specific aspects covered, feel free to ask!

Source link

2025-06-19 14:36:46